Ilumya
tildrakizumab-asmn · Sun Pharma
ILUMYA Early Access Program
Eligible patients experiencing coverage delay may receive initial treatment support.
Up to two doses initially; extended support may be available under defined authorization and appeal rules
| Member ID | Program-assigned |
Show this card to your pharmacist with your prescription.
Program offered by the manufacturer, not YourMD — official terms control and may change. Not valid with Medicare, Medicaid, TRICARE, or other government coverage. YourMD receives no compensation from any manufacturer. Verified Jul 25, 2026 by the YourMDRx clinical team.
Free savings from YourMD Telehealth — board-certified physicians, $20–$50 visits · telehealth.yourmd.online